Aster Volunteers offer free diabetes screening in India and UAE

0
366

Bangalore, December 04, 2021: Aster Volunteers in association with Aster Labs, BioRad and Roche, is offering free Diabetes screening and HbA1c tests to create awareness and promote early screening through Aster Hospitals and Clinics in GCC and India.

Diabetes is certainly becoming a growing area of concern among people around the world. While diabetes used to be more frequent in people above 40, it is now becoming common in all age groups and even adolescents and young adults are at greater risk of getting diabetes than before.

Speaking on the initiative, Mr. T.J Wilson, Executive Director & Group Head Governance & Corporate Affairs, Aster DM Healthcare said, “Although diabetes is one of the fastest-growing lifestyle diseases worldwide, it can be treated, and its consequences avoided or delayed with diet, physical activities, medication, regular screening and treatment for complication. Regular screening is an essential part of the diabetes management process and we sincerely hope that this initiative can help people get detected and bring their disease under control.”

By offering free assessments and tests Aster Volunteers aim to make people aware of an individual’s health status in terms of diabetes, its degree of threat and measures needed to bring the disease under control. Uncontrolled diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves. Adults with diabetes have a two- to three-fold increased risk of heart attacks and strokes. In fact, the impact of Covid-19 is estimated to be much more serious in people with diabetes. Combined with reduced blood flow, neuropathy (nerve damage) in the feet increases the chance of foot ulcers, infection and eventual need for limb amputation. Diabetic retinopathy is an important cause of blindness and occurs as a result of long-term accumulated damage to the small blood vessels in the retina. Close to 1 million people are blind due to diabetes. Diabetes is among the leading causes of kidney failure.

Corporate Comm India (CCI Newswire)